注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-HIV-1 Reference Antibody (Elipovimab)   

Anti-HIV-1 Reference Antibody (Elipovimab)

     
  • 0 - Anti-HIV-1 Reference Antibody (Elipovimab) APR11227
    Anti-HIV-1 Reference Antibody (Elipovimab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-HIV-1 Reference Antibody (Elipovimab) APR11227
    The purity of Anti-HIV-1 Reference Antibody (Elipovimab) is 97.54%, determined by SEC-HPLC.
  • 0 - Anti-HIV-1 Reference Antibody (Elipovimab) APR11227
    Immobilized gp120-YU2 (M_B)-His at 2 µg/mL can bind Elipovimab, EC50= 0.01098 µg/mL.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Reactivity Human
Clonality Monoclonal
Isotype IgG1-ADLEEMLS
Additional Information
Target/Specificity HIV-1
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价